We offer our registered users tailored information, free online courses and exclusive content.
Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?
... or you lost your password?English
This live scientific programme is endorsed by the European Academy of Neurology (EAN)
EXCEMED – Excellence in Medical Education - and the Chairs of the upcoming 2017 Annual conference in multiple sclerosis (3 March 2017, Rome, Italy) invite abstract submissions on the occasion of this international conference.
Prospective presenters are invited to send an abstract on hot topics in multiple sclerosis meeting the following criteria:
Abstracts must be 300 words, written in English and contain:
The conference scientific committee will review abstracts and select the successful applications.
EXCEMED will provide free conference registration, travel, transfer and accommodation to presenters whose abstract has been selected.
Abstract submission deadline: 17 February 2017
Send your abstract to: alessia.addessi@excemed.org
Novel immunological insights into multiple sclerosis (MS) pathogenesis have revolutionized the traditional therapeutic approach. Numerous therapeutic options are available for individuals with MS, but the wide choice may present challenges for clinicians. Selecting the most appropriate treatment – one that targets specific disease manifestations and fulfils patient requirements − has created the need for individual biomarkers to be developed. There is also increasing demand for detailed information about MS to be widely available, particularly with regard to the risk/benefit profiles of specific treatments. Such information needs to be provided directly to patients, who are active players in the ‘therapeutic contract’. The aim of this programme is to update each of these emerging issues in MS, offer practical suggestions for disease management and enhance communication with patients in daily practice.
EXCEMED (www.excemed.org) is accredited by the European Accreditation
Council for Continuing Medical Education (EACCME ® ) to provide the following
CME activity for medical specialists. The EACCME ® is an institution of the
European Union of Medical Specialists (UEMS), www.uems.net
The CME conference “High-quality care for improved patient outcomes"
to be held on 3 March 2017 in Rome, Italy is designated for a maximum of 6 (six) hours of European CME
credits (ECMEC). Each medical specialist should claim only those credits that
he/she actually spent in the educational activity. EACCME ® credits are recognized
by the American Medical Association (AMA) towards the Physician's Recognition
Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please
contact the AMA.
The CME conference has been designated for 2,1 Italian CME Credits. N. Event 178465 Ed.
1 - Provider Id n. 3255 from the Italian Ministry of Health.
8.15 Welcome and opening
8.30 L1 Immunological signatures in relapsing remitting and progressive MS
D. Centonze (Italy)
8.50 L2 The compartmentalized immune response in MS
A. Bar-Or (Canada)
9.10 L3 Neuroinflammation: role of genes and environment
J. Hillert (Sweden)
9.30 Q&A
10.00 Coffee break
10.30 L4 Biomarkers in CNS Demyelinating Diseases
A. Bar-Or (Canada)
10.50 L5 Risks associated with MS treatment
L. Klotz (Germany)
11.10 L6 De-risking strategies in clinical practice
P. Rieckmann (Germany)
11.30 L7 DMDs: long-term studies
G. Comi (Italy)
11.50 PD1 Panel discussion: treatment goals
Moderator: C. Pozzilli (Italy)
12.30 Lunch
This session includes two different parallel workshops, each lasting 1 hour. Participants will be divided into groups and will attend both workshops in rotation. By the end of the session each participant will have attended both workshops.
Workshop I − Predicting treatment response in each patient: switching algorithms in the new landscape
X. Montalban (Spain) and L. Klotz (Germany) Slide kit
Workshop II – How to manage highly active MS patients in practice
G. Comi (Italy) Slide kit and G. Giovannoni (UK) Slide kit
15.30 Coffee break
16.00 L8 The therapeutic contract – the doctor’s perspective
G. Giovannoni (UK)
16.20 L9 The therapeutic contract- the patient’s perspective
R. de Boer (The Netherlands)
16.40 L10 Patient-centered outcomes and clinical trials
A. Solari (Italy)
17.00 Q&A
17.20 Panel discussion: unmet needs in MS
Moderator: D. Bates (UK)
17.50 Scientific highlights and meeting wrap-up
18.00 End of the conference
For registration, accommodation and any logistic inquiry please contact:
Meridiano Congress International (Italy)
Senior Event Manger: Titty Alvino
T +39 06 88 595 310 - F +39 06 88595 234
titty.alvino@meridiano.it
